Advocacy intelligence hub — real-time data for patient organizations
Egaten: FDA approved
EGATEN® is indicated for the treatment of fascioliasis in patients 6 years of age and older.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Egaten
Novartis Pharmaceuticals Corporation